Camp4 Therapeutics Growth Metrics (2023-2026) | CAMP

Growth Metrics Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -151881.0051,668.0011,817.00
EBITDA Margin (QoQ) (Quarter) 62,565.0065,653.00-84683.00-195416.00266,114.0025,802.00
EBIT Margin Growth (1y) (Quarter) -151881.0051,668.0011,817.00
EBIT Margin (QoQ) (Quarter) 62,565.0065,653.00-84683.00-195416.00266,114.0025,802.00
EBT Margin Growth (1y) (Quarter) -110203.0064,655.003,256.00
EBT Margin (QoQ) (Quarter) 8,632.0024,605.00-42947.00-100493.00183,490.0026,341.00
Enterprise Value Growth (1y) (Quarter) 94.99%-66.86%-2,876.86%-73.12%-102.72%-122.84%
Enterprise Value (QoQ) (Quarter) 23.95%-2,433.19%23.02%20.79%-92.70%-47.32%9.85%12.82%
FCF Margin Growth (1y) (Quarter) 356,674.0081,643.00-3972.00
FCF Margin (QoQ) (Quarter) 10,659.0095,548.00-69560.00320,027.00-264372.0012,732.00
Interest Coverage Ratio Growth (1y) (Quarter) 92.01%103.47%1.21%91.15%-1,093.65%-5.35%-1,924.08%76.14%
Interest Coverage Ratio (QoQ) (Quarter) -893.54%92.81%-66.88%93.30%531.72%-304.60%85.04%-803.57%134.23%-4,475.54%9.30%
Net Margin Growth (1y) (Quarter) -110203.0064,655.003,256.00
Net Margin (QoQ) (Quarter) 8,632.0024,605.00-42947.00-100493.00183,490.0026,341.00
Operating Margin Growth (1y) (Quarter) -151881.0051,668.0011,817.00
Operating Margin (QoQ) (Quarter) 62,565.0065,653.00-84683.00-195416.00266,114.0025,802.00
Return on Assets Growth (1y) (Quarter) 1.000.001.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 7,124.002,789.004,218.00
Return on Capital Employed (QoQ) (Quarter) 4,876.00-2486.001,971.002,762.00541.00-1056.00
Return on Sales Growth (1y) (Quarter) 135.00-11.006.000.00
Return on Sales (QoQ) (Quarter) 1.002.00-4.00-10.0018.003.00